The partial rescue of dopaminergic neuronal viability and motor impairment by nilotinib in PARIS Tg mice suggests that signaling pathways other than c-Abl are involved in PARIS-induced PD pathogenesis in vivo. The gene discussed is ABL1; the disease is Parkinson disease.